10-Q: Phreesia Inc. Reports Q2 2025 Results: Revenue Up 19%, Net Loss Improves Significantly

Phreesia Inc. saw a 19% increase in revenue and a significant reduction in net loss for the second quarter of fiscal year 2025, according to its latest 10-Q filing.

Summary

• Phreesia Inc. reported a 19% increase in total revenue, reaching $102.1 million for the three months ended July 31, 2024, compared to $85.8 million for the same period last year.
• The company's net loss improved significantly, decreasing to $18.0 million for the quarter, compared to a net loss of $36.8 million in the same period of the previous year.
• Adjusted EBITDA was $6.5 million for the quarter, a substantial improvement from a negative $11.5 million in the same quarter of the previous year.
• Net cash provided by operating activities was $11.1 million for the quarter, compared to net cash used in operating activities of $9.3 million in the same quarter of the previous year.
• Free cash flow was $3.7 million for the quarter, compared to negative $15.2 million in the same quarter of the previous year.
• For the six months ended July 31, 2024, total revenue increased by 20% to $203.3 million, compared to $169.7 million in the same period of the previous year.
• The net loss for the six months ended July 31, 2024 was $37.7 million, compared to a net loss of $74.3 million in the same period of the previous year.
• Adjusted EBITDA for the six months ended July 31, 2024 was $10.6 million, compared to negative $25.3 million in the same period of the previous year.
• Net cash provided by operating activities for the six months ended July 31, 2024 was $10.3 million, compared to net cash used in operating activities of $23.0 million in the same period of the previous year.
• Free cash flow for the six months ended July 31, 2024 was negative $2.5 million, compared to negative $34.9 million in the same period of the previous year.

Sentiment

Score: 7

Explanation: The document shows strong revenue growth and significant improvements in profitability metrics, but also highlights some challenges such as cybersecurity incidents and reliance on a limited number of clients. The overall sentiment is positive, but with some caution.

Positives

• Subscription and related services revenue increased by 24% for both the three and six months ended July 31, 2024.
• Network solutions revenue increased by 23% for the three months ended July 31, 2024 and 25% for the six months ended July 31, 2024.
• The company's cash and cash equivalents were $81.8 million as of July 31, 2024.
• The company is in compliance with all covenants related to its Capital One Credit Agreement as of July 31, 2024.

Negatives

• Payment processing fees revenue increased by only 7% for the three months ended July 31, 2024 and 9% for the six months ended July 31, 2024, impacted by the Change Healthcare cyber incident and the accelerated wind-down of a relationship with a clearinghouse client.
• Healthcare services revenue per AHSC decreased by 3% for the three months ended July 31, 2024.
• Total revenue per AHSC decreased by 2% for the three months ended July 31, 2024.
• The company experienced a cybersecurity incident with its ConnectOnCall service, which remains partially offline.

Risks

• The company operates in a highly competitive industry, and faces competition from EHR and PM systems.
• The company's operating results may fluctuate significantly, and failure to meet expectations could lead to a decline in stock price.
• Privacy concerns, cyber-attacks, and security breaches could result in economic loss and reputational damage.
• The company is a fully remote company, which subjects it to unique operational risks.
• The company's operations in India subject it to additional risks.
• The company typically incurs significant upfront costs in client relationships, and may not recover these costs.
• The company's sales and implementation cycles are variable, which may lead to fluctuations in quarterly results.
• The company depends on its senior management team and key employees, and the loss of such personnel could adversely affect the business.
• The company may make acquisitions and investments which may be difficult to integrate, divert management resources, or dilute stockholders.
• The company is subject to healthcare laws and data privacy and security laws, which may impose restrictions and penalties.
• The company relies on third-party contractors, vendors, and partners, and replacing them could be difficult and disruptive.

Future Outlook

The company believes that its cash and cash equivalents, along with cash generated in the normal course of business, are sufficient to fund its operations for at least the next 12 months. The company may seek additional financing to implement its long-term strategy.

Management Comments

• Management believes that net losses and negative cash flows will continue for at least the next year.
• Management believes that the company's cash and cash equivalents at July 31, 2024, along with cash generated in the normal course of business and available borrowing capacity under its revolving credit facility with Capital One, are sufficient to fund its operations for at least the next 12 months.

Industry Context

The company operates in the healthcare technology sector, which is characterized by rapid technological advancements and evolving regulatory requirements. The company's performance is influenced by trends such as increasing patient responsibility, engagement, and consumerism in healthcare.

Comparison to Industry Standards

• While the document does not provide specific comparisons to industry standards, the company's revenue growth of 19% and 20% for the three and six months ended July 31, 2024, respectively, indicates a strong performance compared to the broader market.
• The improvement in net loss and adjusted EBITDA suggests that the company is making progress towards profitability, which is a key metric for companies in the healthcare technology sector.
• The company's focus on SaaS-based solutions and payment processing aligns with industry trends towards digital transformation and patient-centric care.
• The company's reliance on a limited number of clients for a significant portion of its revenue is a common risk for companies in this sector, and the company's ability to diversify its client base will be important for long-term growth.
• The company's cybersecurity incidents highlight the importance of robust security measures in the healthcare technology industry, and the company's response to these incidents will be closely watched by investors and clients.

Related Party Transactions

• The company recognized revenue totaling $343 and $671 for the three and six months ended July 31, 2024, respectively, for advertisements placed by a pharmaceutical company where one of the company's independent board members serves on the board of directors.

Stakeholder Impact

• Shareholders will be impacted by the company's improved financial performance and reduced losses.
• Employees may be impacted by the company's growth and potential need for additional resources.
• Customers may be impacted by the company's cybersecurity incidents and the need for continued service improvements.
• Suppliers may be impacted by the company's reliance on third-party relationships and the need for reliable service delivery.
• Creditors may be impacted by the company's improved financial performance and ability to meet its obligations.

Next Steps

• The company will continue to monitor the situation regarding the Change Healthcare cybersecurity incident.
• The company is working diligently to restore the remainder of the ConnectOnCall service.
• The company will continue to evaluate its investment policy to ensure it meets its objectives.

Key Dates

Keywords

SaaS, healthcare, patient engagement, payment processing, software solutions, revenue growth, EBITDA, cybersecurity, data privacy, financial results